---
$id: https://graph.org.ai/products/commodity/51263130
$type: Product
source: UNSPSC
code: "51263130"
title: "Pacrinolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pacrinolol

**UNSPSC Code**: 51263130
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C23H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHE211JZXQ, chemically known as (-)-p-(3-((3,4-dimethoxyphenetyl)amino)-2-hydroxypropoxy)-beta-methylcinnamonitrile but generally known as pacrinolol, which bears US NIH Compound Identifier 6436098. European Medicines Agency schedules Pacrinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09584MIG. The term PACRINOLOL is an International Non-Proprietary Name. PACRINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pacrinolol under HS 29269095 and SITC 51484. As of Q4 2014, PACRINOLOL remains the US FDA Preferred Term for this commodity. Pacrinolol bears US NLM identifiers UMLS ID C0135043 and NCI Concept Code C90800. SMILES: O(CC(O)CNCCC1CC(OC)C(OC)CC1)C1CCC(CC1)/C(=C/C#N)C.

